ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaouat, A
Right arrow Articles by Moutinho dos Santos, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaouat, A
Right arrow Articles by Moutinho dos Santos, J
Eur Respir J 1999; 14: 1002-1008
Copyright © ERS Journals Ltd 1999

Clinical Trial

A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients

A Chaouat, E Weitzenblum, R Kessler, C Charpentier, M Enrhart, R Schott, P Levi-Valensi, J Zielinski, L Delaunois, R Cornudella, and J Moutinho dos Santos

The beneficial effects of nocturnal oxygen therapy (NOT) in chronic obstructive pulmonary disease (COPD) patients with mild-to-moderate daytime hypoxaemia (arterial oxygen tension (Pa,O2) in the range 7.4-9.2 kPa (56-69 mmHg)) and exhibiting sleep-related oxygen desaturation remains controversial. The effectiveness of NOT in that category of COPD patients was studied. The end points included pulmonary haemodynamic effects after 2 yrs of follow-up, survival and requirement for long-term oxygen therapy (LTOT). Seventy-six patients could be randomized, 41 were allocated to NOT and 35 to no NOT (control). The goal of NOT was to achieve an arterial oxygen saturation of >90% throughout the night. All these patients underwent polysomnography to exclude an associated obstructive sleep apnoea syndrome. The two groups exhibited an identical meansD daytime Pa,O2 of 8.4+/-0.4 kPa (63+/-3 mmHg) at baseline. Twenty-two patients (12 in the NOT group and 10 in the control group, p=0.98) required LTOT during the whole follow-up (35+/-14 months). Sixteen patients died, nine in the NOT group and seven in the control group (p=0.84). Forty-six patients were able to undergo pulmonary haemodynamic re-evaluation after 2 yrs, 24 in the NOT and 22 in the control group. In the control group, mean resting pulmonary artery pressure increased from 19.8+/-5.6 to 20.5+6.5 mmHg, which was not different from the change in mean pulmonary artery pressure in the NOT group, from 18.3+/-4.7 to 19.5+/-5.3 mmHg (p= 0.79). Nocturnal oxygen therapy did not modify the evolution of pulmonary haemodynamics and did not allow delay in the prescription of long-term oxygen therapy. No effect of NOT on survival was observed, but the small number of deaths precluded any firm conclusion. These results suggest that the prescription of nocturnal oxygen therapy in isolation is probably not justified in chronic obstructive pulmonary disease patients.


This article has been cited by other articles:


Home page
 Eur Respir JHome page
A. Chaouat, R. Naeije, and E. Weitzenblum
Pulmonary hypertension in COPD
Eur. Respir. J., November 1, 2008; 32(5): 1371 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
V. Kim, J. O. Benditt, R. A. Wise, and A. Sharafkhaneh
Oxygen Therapy in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 513 - 518.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. Krachman, O. A. Minai, and S. M. Scharf
Sleep Abnormalities and Treatment in Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 536 - 542.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
K. Lin, B. Watkins, T. Johnson, J. A. Rodriguez, and M. B. Barton
Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, April 1, 2008; 148(7): 535 - 543.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
A. Qaseem, V. Snow, P. Shekelle, K. Sherif, T. J. Wilt, S. Weinberger, D. K. Owens, and for the Clinical Efficacy Assessment Subcommittee
Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline from the American College of Physicians
Ann Intern Med, November 6, 2007; 147(9): 633 - 638.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
T. J. Wilt, D. Niewoehner, R. MacDonald, and R. L. Kane
Management of Stable Chronic Obstructive Pulmonary Disease: A Systematic Review for a Clinical Practice Guideline
Ann Intern Med, November 6, 2007; 147(9): 639 - 653.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
N. Roche
Where current pharmacological therapies fall short in COPD: symptom control is not enough
Eur. Respir. Rev., September 1, 2007; 16(105): 98 - 104.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Ramsey, R. Mehra, and K. P. Strohl
Variations in Physician Interpretation of Overnight Pulse Oximetry Monitoring
Chest, September 1, 2007; 132(3): 852 - 859.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. R. Casey, K. O. Cantillo, and L. K. Brown
Sleep-Related Hypoventilation/Hypoxemic Syndromes
Chest, June 1, 2007; 131(6): 1936 - 1948.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Q. Fu, N. E. Townsend, S. M. Shiller, E. R. Martini, K. Okazaki, S. Shibata, M. J. Truijens, F. A. Rodriguez, C. J. Gore, J. Stray-Gundersen, et al.
Intermittent hypobaric hypoxia exposure does not cause sustained alterations in autonomic control of blood pressure in young athletes
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1977 - R1984.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
D. D. Sin, N. R. Anthonisen, J. B. Soriano, and A. G. Agusti
Mortality in COPD: role of comorbidities
Eur. Respir. J., December 1, 2006; 28(6): 1245 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. L. Croxton, W. C. Bailey, and for the NHLBI Working Group on Long-term Oxygen Tr
Long-term Oxygen Treatment in Chronic Obstructive Pulmonary Disease: Recommendations for Future Research: An NHLBI Workshop Report
Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 373 - 378.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Statement on Home Care for Patients with Respiratory Disorders
Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1443 - 1464.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J. Zielinski
Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans
Eur. Respir. J., January 1, 2005; 25(1): 173 - 180.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G E Carpagnano, S A Kharitonov, M P Foschino-Barbaro, O Resta, E Gramiccioni, and P J Barnes
Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation
Thorax, December 1, 2004; 59(12): 1016 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. D. Sin, F. A. McAlister, S. F. P. Man, and N. R. Anthonisen
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
JAMA, November 5, 2003; 290(17): 2301 - 2312.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P K Plant and M W Elliott
Chronic obstructive pulmonary disease * 9: Management of ventilatory failure in COPD
Thorax, June 1, 2003; 58(6): 537 - 542.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
C. A. Lewis, T. E. Eaton, W. Fergusson, K. F. Whyte, J. E. Garrett, and J. Kolbe
Home Overnight Pulse Oximetry in Patients With COPD: More Than One Recording May Be Needed
Chest, April 1, 2003; 123(4): 1127 - 1133.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Fujimoto, Y. Matsuzawa, S. Yamaguchi, T. Koizumi, and K. Kubo
Benefits of Oxygen on Exercise Performance and Pulmonary Hemodynamics in Patients With COPD With Mild Hypoxemia*
Chest, August 1, 2002; 122(2): 457 - 463.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P.J. Wijkstra, G.H. Guyatt, N. Ambrosino, B.R. Celli, R. Guell, J.F. Muir, C. Prefaut, E.S. Mendes, I. Ferreira, P. Austin, et al.
International approaches to the prescription of long-term oxygen therapy
Eur. Respir. J., December 1, 2001; 18(6): 909 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
E. Weitzenblum and A. Chaouat
Hypoxic pulmonary hypertension in man: what minimum daily duration of hypoxaemia is required?
Eur. Respir. J., August 1, 2001; 18(2): 251 - 253.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
S. Chinn
Statistics for the European Respiratory Journal
Eur. Respir. J., August 1, 2001; 18(2): 393 - 401.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Chaouat, E. Weitzenblum, R. Kessler, R. Schott, C. Charpentier, P. Levi-Valensi, J. Zielinski, L. Delaunois, R. Cornudella, and J. Moutinho dos Santos
Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation
Eur. Respir. J., May 1, 2001; 17(5): 848 - 855.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
E. C. Fletcher
Physiological and Genomic Consequences of Intermittent Hypoxia: Invited Review: Physiological consequences of intermittent hypoxia: systemic blood pressure
J Appl Physiol, April 1, 2001; 90(4): 1600 - 1605.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
M.-F. Beauchesne
Management of Chronic Obstructive Pulmonary Disease: A Review
Journal of Pharmacy Practice, April 1, 2001; 14(2): 126 - 142.
[Abstract] [PDF]

Home page
 NEJMHome page
S. Sethi, T. F. Murphy, K. L. Nichol, T. K. Marras, L. C. Marras, and P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., December 28, 2000; 343(26): 1969 - 1971.
[Full Text]

Home page
 NEJMHome page
P. J. Barnes
Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., July 27, 2000; 343(4): 269 - 280.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the European Respiratory Society.